SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-307810
Filing Date
2022-12-19
Accepted
2022-12-19 06:05:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d411811dsc13g.htm SC 13G 44529
  Complete submission text file 0001193125-22-307810.txt   46040
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Subject) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92440 | Film No.: 221469539
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814
Business Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814 301-951-4422
Cystic Fibrosis Foundation (Filed by) CIK: 0001957515 (see all company filings)

IRS No.: 131930701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G